8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Feb 4, 2026·SEC
Material company update
Feb 2, 2026·SEC
CME Group Inc.(CME)Earnings, Financials & Key Ratios
CME•NASDAQ•Banking & Credit
22.1× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryFinancial Data & ExchangesSub-IndustryExchanges, Clearing and Trading Venues
AboutCME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.Show more
- Net Interest Income-$130M+19.4%
- Total Revenue$6.52B+6.4%
- Net Income$4.04B+14.7%
- Return on Equity14.65%+10.6%
- Net Interest Margin-0.07%+44.2%
- Efficiency Ratio21.23%-3.5%
- ROA2.41%-8.8%
- Equity / Assets14.47%-24.9%
- Book Value per Share79.75+8.4%
CME Key Insights
CME Group Inc. (CME) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Efficient operations: 21.2% efficiency ratio
- ✓15 consecutive years of dividend growth
- ✓Well capitalized: 14.5% equity/assets
- ✓Healthy dividend yield of 4.4%
- ✓Diversified revenue: 100.0% from non-interest income
✗Weaknesses
- ✗Weak NIM of -0.1%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CME posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CME Price & Volume
CME Group Inc. (CME) stock price & volume — 10-year historical chart
Loading chart...
CME Growth Metrics
CME Group Inc. (CME) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.96%
5 Years5.95%
3 Years9.11%
TTM-
Profit CAGR
10 Years12.49%
5 Years13.95%
3 Years14.55%
TTM16.98%
EPS CAGR
10 Years11.7%
5 Years13.71%
3 Years14.68%
TTM17.91%
Return on Capital
10 Years7.66%
5 Years7.92%
3 Years8.02%
Last Year3.62%
CME Recent Earnings
CME Group Inc. (CME) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 22, 2026Metric
Actual
Est
EPS
$3.36+0.6%
$3.34
Rev
$1.9B+0.3%
$1.9B
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$2.77+0.7%
$2.75
Rev
$1.6B+0.1%
$1.6B
Q4 2025
Oct 22, 2025Metric
Actual
Est
EPS
$2.68+1.9%
$2.63
Rev
$1.5B+0.5%
$1.5B
Q3 2025
Jul 23, 2025Metric
Actual
Est
EPS
$2.96+1.7%
$2.91
Rev
$1.7B+0.4%
$1.7B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $3.36vs $3.34+0.6% | $1.9Bvs $1.9B+0.3% |
| Q1 2026 | Feb 4, 2026 | $2.77vs $2.75+0.7% | $1.6Bvs $1.6B+0.1% |
| Q4 2025 | Oct 22, 2025 | $2.68vs $2.63+1.9% | $1.5Bvs $1.5B+0.5% |
| Q3 2025 | Jul 23, 2025 | $2.96vs $2.91+1.7% | $1.7Bvs $1.7B+0.4% |
Based on last 12 quarters of dataView full earnings history →
CME Peer Comparison
CME Group Inc. (CME) competitors in Exchanges, Clearing and Trading Venues — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ICE | 75.83B | 133.88 | 23.20 | 7.46% | 26.14% | 11.57% | 0.70 | |
 CBOE | 26.09B | 249.10 | 23.91 | 15.13% | 23.33% | 22.99% | 0.33 | |
 NDAQ | 46.75B | 82.24 | 26.61 | 11.05% | 23.15% | 15.9% | 0.81 | |
 MKTX | 4.28B | 120.33 | 18.07 | 3.82% | 35.34% | 24.02% | 0.25 | |
 MSCI | 42.31B | 581.19 | 37.35 | 9.74% | 40.74% | |||
 SPGI | 121.63B | 410.92 | 28.03 | 7.94% | 30.37% | 12.92% | 0.39 | |
 FDS | 8.2B | 221.29 | 14.23 | 5.39% | 24.48% | 27.22% | 0.71 | |
 TW | 21.2B | 99.49 | 26.32 | 18.92% | 40.25% | 12.35% | 0.04 |
Compare CME vs Peers
CME Group Inc. (CME) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CME Income Statement
CME Group Inc. (CME) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Net Interest Income | -117M | -157.7M | -178M | -166.2M | -166.9M | -162.7M | -159.4M | -160.9M | -129.7M | 1.65B |
NII Growth % | 5.26% | -34.79% | -12.87% | 6.63% | -0.42% | 2.52% | 2.03% | -0.94% | 19.39% | 4441.62% |
Net Interest Margin % | -0.15% | -0.2% | -0.24% | -0.13% | -0.08% | -0.09% | -0.12% | -0.12% | -0.07% | 0.81% |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.78B |
Interest Expense | 117M | 157.7M | 178M | 166.2M | 166.9M | 162.7M | 159.4M | 160.9M | 129.7M | 131.6M |
Loan Loss Provision | 446.9M | 514.5M | 720.7M | 690.3M | 670.1M | 590.4M | 669.2M | 689.4M | 777.3M | 791.7M |
Non-Interest Income | 3.64B | 4.31B | 4.87B | 4.88B | 4.69B | 5.02B | 5.58B | 6.13B | 6.52B | 4.98B |
Non-Interest Income % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 73.71% |
Total Revenue | 3.64B▲ 0% | 4.31B▲ 18.2% | 4.87B▲ 13.0% | 4.88B▲ 0.3% | 4.69B▼ 4.0% | 5.02B▲ 7.0% | 5.58B▲ 11.1% | 6.13B▲ 9.9% | 6.52B▲ 6.4% | 6.76B▲ 0% |
Revenue Growth % | 1.38% | 18.24% | 12.96% | 0.32% | -3.97% | 7.03% | 11.15% | 9.88% | 6.37% | 30.02% |
Non-Interest Expense | 745.9M | 1.03B | 1.38B | 1.39B | 1.21B | 1.25B | 1.31B | 1.35B | 1.38B | 1.4B |
Efficiency Ratio | 20.47% | 23.89% | 28.38% | 28.46% | 25.75% | 24.91% | 23.56% | 21.99% | 21.23% | 20.77% |
Operating Income | 2.31B▲ 0% | 2.61B▲ 12.9% | 2.59B▼ 0.8% | 2.64B▲ 1.9% | 2.65B▲ 0.3% | 3.02B▲ 14.0% | 3.44B▲ 13.9% | 3.93B▲ 14.4% | 4.23B▲ 7.6% | 4.43B▲ 0% |
Operating Margin % | 63.4% | 60.51% | 53.16% | 54.01% | 56.4% | 60.08% | 61.58% | 64.13% | 64.86% | 65.57% |
Operating Income Growth % | 5% | 12.85% | -0.76% | 1.92% | 0.3% | 14.01% | 13.92% | 14.43% | 7.58% | - |
Pretax Income | 2.53B▲ 0% | 2.78B▲ 10.0% | 2.69B▼ 3.2% | 2.72B▲ 1.2% | 3.37B▲ 23.9% | 3.49B▲ 3.5% | 4.15B▲ 19.0% | 4.54B▲ 9.3% | 5.33B▲ 17.4% | 5.6B▲ 0% |
Pretax Margin % | 69.31% | 64.46% | 55.25% | 55.74% | 71.94% | 69.54% | 74.45% | 74.08% | 81.75% | 82.81% |
Income Tax | -1.54B | 814.1M | 573.8M | 615.7M | 736.7M | 799.3M | 927.4M | 1.02B | 1.27B | 1.34B |
Effective Tax Rate % | -60.84% | 29.31% | 21.33% | 22.62% | 21.84% | 22.9% | 22.33% | 22.36% | 23.89% | 23.96% |
Net Income | 4.06B▲ 0% | 1.96B▼ 51.7% | 2.12B▲ 7.9% | 2.11B▼ 0.5% | 2.64B▲ 25.2% | 2.69B▲ 2.1% | 3.23B▲ 19.9% | 3.53B▲ 9.3% | 4.04B▲ 14.7% | 4.24B▲ 0% |
Net Margin % | 111.49% | 45.53% | 43.48% | 43.11% | 56.22% | 53.61% | 57.83% | 57.52% | 62.02% | 62.77% |
Net Income Growth % | 164.87% | -51.71% | 7.86% | -0.53% | 25.23% | 2.07% | 19.89% | 9.29% | 14.71% | 16.98% |
Net Income (Continuing) | 4.06B | 1.96B | 2.12B | 2.11B | 2.64B | 2.69B | 3.23B | 3.53B | 4.06B | 4.26B |
EPS (Diluted) | 11.94▲ 0% | 5.71▼ 52.2% | 5.91▲ 3.5% | 5.87▼ 0.7% | 7.29▲ 24.2% | 7.40▲ 1.5% | 8.86▲ 19.7% | 9.67▲ 9.1% | 11.16▲ 15.4% | 11.68▲ 0% |
EPS Growth % | 163.58% | -52.18% | 3.5% | -0.68% | 24.19% | 1.51% | 19.73% | 9.14% | 15.41% | 17.91% |
EPS (Basic) | 12.00 | 5.73 | 5.93 | 5.88 | 7.30 | 7.41 | 8.87 | 9.69 | 11.18 | - |
Diluted Shares Outstanding | 340.23M | 343.74M | 358.24M | 358.52M | 358.93M | 359.18M | 359.5M | 359.94M | 360.23M | 363.21M |
CME Balance Sheet
CME Group Inc. (CME) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short Term Investments | 1.99B | 1.45B | 1.63B | 1.73B | 2.95B | 2.82B | 3.02B | 3.01B | 4.55B | 11.73B |
Cash & Due from Banks | 1.9B | 1.37B | 1.55B | 1.63B | 2.83B | 2.72B | 2.91B | 2.89B | 4.42B | 2.39B |
Short Term Investments | 90.1M | 72.9M | 83.2M | 100.9M | 115M | 96M | 111.7M | 113.2M | 125M | 124.2M |
Total Investments | 90.1M | 72.9M | 83.2M | 100.9M | 115M | 96M | 111.7M | 113.2M | 1.63B | 124.2M |
Investments Growth % | 8.16% | -19.09% | 14.13% | 21.27% | 13.97% | -16.52% | 16.35% | 1.34% | 1335.95% | 1351.33% |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5B | 1.5B |
Accounts Receivables | 359.7M | 553.3M | 491.8M | 461.3M | 434.5M | 483.2M | 535.6M | 573.1M | 639.2M | 935.5M |
Goodwill & Intangibles | 27.09B | 33.48B | 33.04B | 32.84B | 31.24B | 30.93B | 30.72B | 30.48B | 30.3B | 27.68B |
Goodwill | 7.57B | 10.81B | 10.74B | 10.8B | 10.53B | 10.48B | 10.5B | 10.49B | 10.51B | 10.51B |
Intangible Assets | 19.52B | 22.68B | 22.29B | 22.04B | 20.71B | 20.45B | 20.23B | 20B | 19.79B | 17.18B |
PP&E (Net) | 399.7M | 448.7M | 544M | 579.2M | 505.3M | 455.5M | 409.5M | 386.2M | 573M | 355.4M |
Other Assets | 1.39B | 1.66B | 2.07B | 1.96B | 3.28B | 3.71B | 3.69B | 3.54B | 160.86B | 4.96B |
Total Current Assets | 46.91B | 41.89B | 39.57B | 89.28B | 161.76B | 139.08B | 94.89B | 103.03B | 5.19B | 169B |
Total Non-Current Assets | 28.88B | 35.59B | 35.65B | 35.38B | 35.02B | 35.1B | 34.82B | 34.41B | 193.36B | 32.99B |
Total Assets | 75.79B▲ 0% | 77.48B▲ 2.2% | 75.22B▼ 2.9% | 124.66B▲ 65.7% | 196.78B▲ 57.9% | 174.18B▼ 11.5% | 129.71B▼ 25.5% | 137.45B▲ 6.0% | 198.55B▲ 44.5% | 201.99B▲ 0% |
Asset Growth % | 9.26% | 2.22% | -2.92% | 65.74% | 57.85% | -11.49% | -25.53% | 5.97% | 44.45% | 154.06% |
Return on Assets (ROA) | 5.6% | 2.56% | 2.77% | 2.11% | 1.64% | 1.45% | 2.12% | 2.64% | 2.41% | 2.21% |
Accounts Payable | 31.3M | 116M | 61.9M | 69.3M | 48.8M | 121.4M | 90.6M | 79.9M | 71.8M | 75.4M |
Total Debt | 46.42B | 4.4B | 3.74B | 3.44B | 3.45B | 3.44B | 3.43B | 3.43B | 3.76B | 3.42B |
Net Debt | 44.51B | 3.03B | 2.19B | 1.81B | 610.2M | 718.3M | 513.4M | 535.6M | -666.2M | 1.03B |
Long-Term Debt | 2.23B | 3.83B | 3.74B | 3.44B | 2.7B | 3.42B | 3.43B | 2.68B | 3.42B | 3.42B |
Short-Term Debt | 44.19B | 574.2M | 0 | 0 | 749.4M | 16M | 0 | 749.8M | 55.8M | 0 |
Other Liabilities | 615.7M | 745.1M | 1.16B | 1.06B | 896.5M | 826M | 798.2M | 721.2M | 160.7B | 733.2M |
Total Current Liabilities | 45.67B | 41.27B | 38.52B | 88.2B | 160.4B | 137.69B | 93.42B | 102.31B | 55.8M | 166B |
Total Non-Current Liabilities | 7.71B | 10.24B | 10.53B | 10.11B | 8.98B | 9.61B | 9.55B | 8.65B | 169.76B | 9.38B |
Total Liabilities | 53.38B | 51.51B | 49.06B | 98.31B | 169.38B | 147.3B | 102.97B | 110.96B | 169.82B | 175.38B |
Total Equity | 22.41B▲ 0% | 25.97B▲ 15.9% | 26.16B▲ 0.7% | 26.35B▲ 0.7% | 27.4B▲ 4.0% | 26.88B▼ 1.9% | 26.74B▼ 0.5% | 26.49B▼ 0.9% | 28.73B▲ 8.5% | 26.62B▲ 0% |
Equity Growth % | 10.18% | 15.86% | 0.75% | 0.73% | 3.98% | -1.9% | -0.52% | -0.94% | 8.46% | 7.22% |
Equity / Assets (Capital Ratio) | 29.57% | 33.51% | 34.78% | 21.14% | 13.92% | 15.43% | 20.61% | 19.27% | 14.47% | 13.18% |
Return on Equity (ROE) | 19.01% | 8.11% | 8.12% | 8.02% | 9.81% | 9.92% | 12.03% | 13.25% | 14.65% | 15.25% |
Book Value per Share | 65.87 | 75.54 | 73.02 | 73.50 | 76.34 | 74.83 | 74.38 | 73.59 | 79.75 | 73.29 |
Tangible BV per Share | -13.75 | -21.86 | -19.19 | -18.10 | -10.69 | -11.27 | -11.08 | -11.10 | -4.37 | -2.93 |
Common Stock | 3.4M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M |
Additional Paid-in Capital | 17.9B | 21.05B | 21.11B | 21.19B | 22.19B | 22.26B | 22.33B | 22.4B | 22.21B | 0 |
Retained Earnings | 4.5B | 4.86B | 5.01B | 5B | 5.15B | 4.75B | 4.46B | 4.19B | 6.43B | 4.88B |
Accumulated OCI | 14.3M | 5.3M | 3.4M | 134.9M | 53.5M | -133.3M | -55.6M | -105.5M | 81.9M | 59.4M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CME Cash Flow Statement
CME Group Inc. (CME) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.84B | 2.44B | 2.67B | 2.72B | 2.4B | 3.06B | 3.45B | 3.69B | 4.28B | 4.42B |
Operating CF Growth % | 7.25% | 32.62% | 9.51% | 1.6% | -11.53% | 27.21% | 13.02% | 6.85% | 15.89% | 57% |
Net Income | 4.06B | 1.96B | 2.12B | 2.11B | 2.64B | 2.69B | 3.23B | 3.53B | 4.04B | 4.24B |
Depreciation & Amortization | 208.5M | 248.7M | 473.3M | 464.4M | 385.4M | 362.6M | 352.6M | 336.8M | 223.4M | 390.3M |
Deferred Taxes | -2.36B | 114.3M | -3.7M | -41.6M | 34.8M | -23.2M | -75M | -66.4M | -6.1M | -32.1M |
Other Non-Cash Items | -115M | -32.1M | 48.9M | 31.2M | -568.1M | 36.5M | -37.7M | -3.6M | -217.5M | -450.7M |
Working Capital Changes | -16.7M | 49.7M | -34.6M | 59.2M | -161.8M | -95.2M | -95.2M | -191.6M | 138.1M | 102.5M |
Cash from Investing | 179.9M | -1.89B | -152.6M | -175.5M | 58.4M | -489.8M | 20.9M | -82.6M | 1.5B | 1.49B |
Purchase of Investments | -3M | -10M | -15.4M | -11.1M | -7.8M | -4.4M | -4.1M | -4.5M | -6M | -5.7M |
Sale/Maturity of Investments | 266.1M | 11.8M | 18.8M | 12.3M | 9.4M | 6.3M | 5.9M | 6M | 7.9M | 8M |
Net Investment Activity | 263.1M | 1.8M | 3.4M | 1.2M | 1.6M | 1.9M | 1.8M | 1.5M | 1.9M | 2.3M |
Acquisitions | -1.3M | -1.77B | 89.6M | 20.8M | 144.7M | -402M | 95.5M | 9.9M | 1.58B | 1.58B |
Other Investing | 261.8M | 0 | 0 | 0 | 39.3M | 0 | 0 | 0 | 0 | -20.6M |
Cash from Financing | -1.99B | -1.08B | -2.34B | -2.46B | 69.91B | -25.38B | -48.34B | 5.08B | 56.51B | 39.41B |
Dividends Paid | -1.99B | -2.15B | -1.7B | -2.11B | -2.19B | -2.63B | -3.24B | -3.58B | -3.93B | -4.06B |
Share Repurchases | 0 | 0 | -36.8M | -41.4M | 0 | -24.8M | -21.4M | -33M | -266.1M | -547.5M |
Stock Issued | 36.7M | 398.4M | 36.8M | 0 | 965M | 0 | 0 | 0 | 0 | 0 |
Net Stock Activity | 36.7M | 398.4M | 0 | -41.4M | 965M | -24.8M | -21.4M | -33M | -266.1M | -547.5M |
Debt Issuance (Net) | 0 | 1000K | -1000K | -1000K | 0 | -1000K | -1000K | 0 | -1000K | -1000K |
Other Financing | -28.5M | -447.9M | 53.6M | -2.2M | 71.13B | -22.71B | -45.07B | 8.69B | 60.72B | 43.49B |
Net Change in Cash | 35M▲ 0% | -528.8M▼ 1610.9% | 179.4M▲ 133.9% | 81.9M▼ 54.3% | 72.37B▲ 88263.2% | -22.82B▼ 131.5% | -44.86B▼ 96.6% | 8.68B▲ 119.4% | 1.52B▼ 82.4% | 3.01B▲ 0% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60.76B | -38.96B |
Cash at Beginning | 1.87B | 1.91B | 1.38B | 1.56B | 88.42B | 160.79B | 137.97B | 93.11B | 2.9B | 0 |
Cash at End | 1.9B | 1.38B | 1.56B | 1.64B | 160.79B | 137.97B | 93.11B | 101.79B | 4.42B | 0 |
Interest Paid | 84.8M | 108.3M | 146.3M | 133.3M | 133.3M | 133.2M | 129.9M | 129.9M | 135.6M | 94.5M |
Income Taxes Paid | 762.8M | 577.4M | 591.2M | 652.7M | 755M | 973.4M | 1.11B | 1.2B | 1.16B | 1.15B |
Free Cash Flow | 1.76B▲ 0% | 2.32B▲ 32.2% | 2.43B▲ 4.4% | 2.52B▲ 3.7% | 2.28B▼ 9.6% | 2.97B▲ 30.4% | 3.38B▲ 13.9% | 3.6B▲ 6.5% | 4.19B▲ 16.6% | 4.35B▲ 0% |
FCF Growth % | 8.27% | 32.16% | 4.44% | 3.75% | -9.65% | 30.38% | 13.86% | 6.49% | 16.6% | 13.72% |
CME Banking Ratios
CME Group Inc. (CME) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 19.01% | 8.11% | 8.12% | 8.02% | 9.81% | 9.92% | 12.03% | 13.25% | 14.65% | 15.25% |
Return on Assets (ROA) | 5.6% | 2.56% | 2.77% | 2.11% | 1.64% | 1.45% | 2.12% | 2.64% | 2.41% | 2.21% |
Net Interest Margin | -0.15% | -0.2% | -0.24% | -0.13% | -0.08% | -0.09% | -0.12% | -0.12% | -0.07% | 0.81% |
Efficiency Ratio | 20.47% | 23.89% | 28.38% | 28.46% | 25.75% | 24.91% | 23.56% | 21.99% | 21.23% | 20.77% |
Equity / Assets | 29.57% | 33.51% | 34.78% | 21.14% | 13.92% | 15.43% | 20.61% | 19.27% | 14.47% | 13.18% |
Book Value / Share | 65.87 | 75.54 | 73.02 | 73.5 | 76.34 | 74.83 | 74.38 | 73.59 | 79.75 | 73.29 |
NII Growth | 5.26% | -34.79% | -12.87% | 6.63% | -0.42% | 2.52% | 2.03% | -0.94% | 19.39% | 1111.12% |
Dividend Payout | 49.06% | 109.57% | 80.13% | 100.23% | 83.04% | 97.86% | 100.29% | 101.66% | 97.25% | 32.19% |
Related:CME Dividend History·CME Revenue History·CME Price History·CME P/E History·CME Financial Ratios·CME Institutional Holders
CME SEC Filings & Documents
CME Group Inc. (CME) SEC filings — annual & quarterly reports (10-K, 10-Q)
CME Frequently Asked Questions
CME Group Inc. (CME) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
CME Group Inc. (CME) grew revenue by 6.4% over the past year. This is steady growth.
Yes, CME Group Inc. (CME) is profitable, generating $4.24B in net income for fiscal year 2025 (62.0% net margin).
Dividend & Returns
Yes, CME Group Inc. (CME) pays a dividend with a yield of 4.43%. This makes it attractive for income-focused investors.
CME Group Inc. (CME) has a return on equity (ROE) of 14.6%. This is reasonable for most industries.
Industry Metrics
CME Group Inc. (CME) has a net interest margin (NIM) of -0.1%. NIM has been under pressure due to interest rate environment.
CME Group Inc. (CME) has an efficiency ratio of 21.2%. This is excellent, indicating strong cost control.